Ocumension Therapeutics (HKG:1477)
Hong Kong · Delayed Price · Currency is HKD 7.33
+0.37 (5.32%)
At close: Mar 27, 2026
Ocumension Therapeutics Market Cap
Ocumension Therapeutics has a market cap or net worth of 5.98 billion as of March 27, 2026. Its market cap has increased by 57.11% in one year.
Market Cap
5.98B
Enterprise Value
5.74B
Revenue
895.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.33
Market Cap Chart
Since July 10, 2020, Ocumension Therapeutics's market cap has decreased from 21.28B to 5.98B, a decrease of -71.92%. That is a compound annual growth rate of -19.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 5.68B | -5.95% |
| Dec 31, 2025 | 6.03B | 64.39% |
| Dec 31, 2024 | 3.67B | -20.44% |
| Dec 29, 2023 | 4.61B | -30.21% |
| Dec 30, 2022 | 6.61B | -43.35% |
| Dec 31, 2021 | 11.67B | -26.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Haohai Biological Technology | 9.06B |
| Abbisko Cayman | 8.37B |
| Alphamab Oncology | 7.50B |
| CK Life Sciences Int'l., (Holdings) | 6.44B |
| Laekna | 6.42B |
| Jacobio Pharmaceuticals Group | 5.15B |
| Beijing Luzhu Biotechnology | 4.58B |
| BioDlink International Company | 4.41B |